Disease · EFO_1001896

lateral epicondylitis

6 sourcesdiseases-2026-09-18-0.1.0

Cite this record

ConductScience Library. lateral epicondylitis. Diseases, record EFO_1001896. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/EFO_1001896

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name: lateral epicondylitis; Open Targets
Open Targets ID: EFO_1001896; Open Targets
Other names: archer's elbow, golfer's elbow, hockey elbow, lateral epicondylalgia, lateral humeral epicondylitis, tennis elbow; Open Targets
Disease Ontology: DOID:14088; Disease Ontology
MeSH: D013716; MeSH
NCI Thesaurus: C35067; NCI Thesaurus
Highest stage of its drugs: Approval, for 6 of its 33 drugs, from DailyMed; Open Targets

Drugs33

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Drug	ChEMBL ID	Type	Open Targets' stage	Stage reported by	Reports	Of them trials	Trials shown here	Source
DEXAMETHASONE	CHEMBL384467	Small molecule	Approval	DailyMed	10	8	3	Drugs and targets
TRIAMCINOLONE ACETONIDE	CHEMBL1504	Small molecule	Approval	DailyMed	8	7	2	Drugs and targets
PREDNISOLONE	CHEMBL131	Small molecule	Approval	DailyMed	7	6	0	Drugs and targets
PREDNISONE	CHEMBL635	Small molecule	Approval	DailyMed	7	6	0	Drugs and targets
DEXAMETHASONE SODIUM PHOSPHATE	CHEMBL2021430	Small molecule	Approval	DailyMed	2	0	0	Drugs and targets
CORTISONE ACETATE	CHEMBL1650	Small molecule	Approval	DailyMed	1	0	0	Drugs and targets
METHYLPREDNISOLONE	CHEMBL650	Small molecule	Phase 3	ClinicalTrials.gov	8	8	2	Drugs and targets
METHYLPREDNISOLONE ACETATE	CHEMBL1364144	Small molecule	Phase 3	ClinicalTrials.gov	6	6	1	Drugs and targets
BETAMETHASONE	CHEMBL632	Small molecule	Phase 3	ClinicalTrials.gov	5	5	0	Drugs and targets
BETAMETHASONE DIPROPIONATE	CHEMBL1200384	Small molecule	Phase 3	ClinicalTrials.gov	5	5	0	Drugs and targets

1 to 10 of 33

See all 33 drugs

Targets24

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

Target	Protein	Its drugs that act on it	Mechanisms	Highest stage of those drugs	Gene in Genes	Source
NR3C1	Glucocorticoid receptor	13	Glucocorticoid receptor agonist	Approval	https://conductscience.org/library/genes/2908	Drugs and targets
PTGS1	Cyclooxygenase	5	Cyclooxygenase inhibitor	Phase 3	https://conductscience.org/library/genes/5742	Drugs and targets
PTGS2	Cyclooxygenase	5	Cyclooxygenase inhibitor	Phase 3	https://conductscience.org/library/genes/5743	Drugs and targets
SNAP25	Synaptosomal-associated protein 25	4	Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme; Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor	Phase 3	https://conductscience.org/library/genes/6616	Drugs and targets
GUCY1A1	Soluble guanylate cyclase	1	Soluble guanylate cyclase activator	Phase 2	https://conductscience.org/library/genes/2982	Drugs and targets
GUCY1A2	Soluble guanylate cyclase	1	Soluble guanylate cyclase activator	Phase 2	https://conductscience.org/library/genes/2977	Drugs and targets
GUCY1B1	Soluble guanylate cyclase	1	Soluble guanylate cyclase activator	Phase 2	https://conductscience.org/library/genes/2983	Drugs and targets
MMP1	Interstitial collagenase	1	Matrix metalloproteinase-1 inhibitor	Unknown	https://conductscience.org/library/genes/4312	Drugs and targets
MMP13	Collagenase 3	1	Matrix metalloproteinase 13 inhibitor	Unknown	https://conductscience.org/library/genes/4322	Drugs and targets
MMP7	Matrilysin	1	Matrix metalloproteinase 7 inhibitor	Unknown	https://conductscience.org/library/genes/4316	Drugs and targets

1 to 10 of 24

See all 24 targets

Trials31

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 5 more are not shown, since the checks do not confirm them.

Trial	Title	Phase	Participants	Results first posted	Conditions	Drugs	Linked by	Source
NCT02266433	Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders	Phase 3	245	2020-11-02	DeQuervains Tenosynovitis, Lateral Epicondylitis, Tennis Elbow, Trigger Finger, Tenosynovitis, Inflammatory Disease	DEXAMETHASONE, KETOROLAC	Its record names the disease	ClinicalTrials.gov
NCT00674622	Prolotherapy for the Treatment of Chronic Lateral Epicondylitis	Phase 2/3	67	2016-05-16	Lateral Epicondylitis, Tennis Elbow	DEXTROSE	Its record names the disease	ClinicalTrials.gov
NCT00794976	Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis	Phase 2	216		Lateral Epicondylitis, (Tennis Elbow)	DEXAMETHASONE	Its record names the disease	ClinicalTrials.gov
NCT05648032	PLT and Steroid in Lateral Epicondylopathy and Supraspinatus Calcific Tendinopathy	Phase 3	180		Lateral Epicondylitis, Rotator Cuff Syndrome	TRIAMCINOLONE ACETONIDE	Its record names the disease	ClinicalTrials.gov
NCT07475663	Counterpain PXM Versus Diclofenac Versus Piroxicam	Phase 3	180		Ankle Sprain, Back Pain, Osteoarthritis (OA) of the Knee, Tennis Elbow, Runner's Knee	DICLOFENAC SODIUM, PIROXICAM	Its record names the disease	ClinicalTrials.gov
NCT00447928	Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow	Phase 2	164		Tendonitis	NITROGLYCERIN	Its record names the disease	ClinicalTrials.gov
NCT04445727	Efficacy of Vitamin C Supplement vs Spinal Manipulation to Treatment in Lateral Epicondylitis	Not applicable	130		Lateral Epicondylitis, Tennis Elbow	ASCORBIC ACID	Its record names the disease	ClinicalTrials.gov
NCT06236178	Comparing Autologous Blood, Corticosteroid, and Their Combined Injection for Treating Lateral Epicondylitis	Not applicable	119		Lateral Epicondylitis, Comparing Autologous Blood Corticosteroid and Their Combined Injection for Treating Lateral Epicondylitis	METHYLPREDNISOLONE ACETATE	Its record names the disease	ClinicalTrials.gov
NCT00757289	Platelet-rich-plasma Treating Tennis Elbow	Not applicable	106		Pain	PLATELET CONCENTRATE	Its record names the disease	ClinicalTrials.gov
NCT00930709	Botulinum Toxin Versus Active Strength Training in the Treatment of Lateral Epicondylitis	Not applicable	103		Epicondylitis, Lateral Humeral, Tennis Elbow	BOTULINUM TOXIN TYPE A	Its record names the disease	ClinicalTrials.gov

1 to 10 of 31

See all 31 trials

Comparisons in its trials2

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

Comparison	Group 1, with the outcome	Group 2, with the outcome	Participants	Trial	Source
Arm Receiving Dexamethasone Injection vs Arm Receiving Ketorolac Injection: deaths from any cause	0 of 127	0 of 118	245	NCT02266433	Trial comparisons
Arm Receiving Dexamethasone Injection vs Arm Receiving Ketorolac Injection: serious adverse events	0 of 127	0 of 118	245	NCT02266433	Trial comparisons

Papers from its trials20

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it	Source
31518778	RESULT	1	PubMed
29734897	RESULT	1	PubMed
28861199	RESULT	1	PubMed
28828509	RESULT	1	PubMed
26392595	RESULT	1	PubMed
26361816	RESULT	1	PubMed
26149189	RESULT	1	PubMed
25246239	RESULT	1	PubMed
24378321	RESULT	1	PubMed
22923162	RESULT	1	PubMed

1 to 10 of 20

See all 20 papers from its trials

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
Drug links and their checks, from Drugs and targets: 2026-09-18; Drugs and targets
ClinicalTrials.gov, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
PubMed, for the checks: 2026-11-06; PubMed
MeSH, for the checks: 2026-11-10; MeSH

Sources 6

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/EFO_1001896

GET https://conductscience.org/api/diseases/v1/EFO_1001896/drugs?page=2

API reference For AI assistants